Form 4: Zimmer Biomet Insider Trades: Noor Jehanzeb Acquires Shares

Zimmer Biomet Holdings, Inc. reports insider transactions, with Noor Jehanzeb acquiring shares and RSUs.

Summary

• Noor Jehanzeb, an officer of Zimmer Biomet Holdings, Inc., reported transactions on April 1, 2026.
• Jehanzeb acquired 6,626 shares of common stock at $0 cost.
• Additionally, 1,677 shares were withheld by the company to cover tax withholdings on vested Restricted Stock Units (RSUs).
• The filing also details the vesting of RSUs, with one-third vesting on April 1, 2026, and the remainder vesting in two equal installments on April 1, 2027, and April 1, 2028.
• Following these transactions, Jehanzeb beneficially owns 6,828 shares directly and an additional 5,151 shares directly, with 13,249 RSUs also held.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine insider stock transactions and vesting schedules rather than significant financial performance or strategic shifts.

Positives

• Insider acquisition of shares at no cost suggests confidence in the company's future.
• Vesting of RSUs indicates continued employee engagement and potential for future share ownership.
• The acquisition of 6,626 shares at $0 cost is a direct increase in beneficial ownership for the reporting person.

Negatives

• 1,677 shares were withheld for tax purposes, reducing the net shares received from vested RSUs.

Future Outlook

The vesting schedule for the remaining RSUs indicates a phased increase in beneficial ownership for Noor Jehanzeb over the next two years.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock dealings within the medical device industry.

Stakeholder Impact

• Shareholders gain transparency into insider stock ownership changes.
• Employees, specifically Noor Jehanzeb, benefit from equity compensation through RSU vesting.

Next Steps

• Vesting of remaining Restricted Stock Units on April 1, 2027, and April 1, 2028.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities Exchange Act